Clinical trial
Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression
NCT00406848 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- November 30, 2009
- Enrollment
- 370 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.